Preclinical Models of Neuroblastoma-Current Status and Perspectives.

Area of Science:

• Oncology
• Cancer Research
• Translational Medicine

Background:

• Preclinical models are essential for cancer research, aiding basic and translational studies.
• Existing in vitro and in vivo models, including cell cultures and animal models, have limitations in fully replicating human cancer complexity.
• There is a critical need for advanced preclinical models that better reflect disease pathophysiology and guide therapeutic strategies.

Purpose of the Study:

• To review the current landscape of preclinical models for neuroblastoma research.
• To discuss the strengths and limitations of existing neuroblastoma models.
• To highlight the necessity for developing novel, more clinically relevant preclinical approaches for neuroblastoma.

Main Methods:

• Review of existing literature on preclinical cancer models.
• Analysis of current in vitro (2D, 3D cell culture) and in vivo (animal) models.
• Discussion of model characteristics, including relevance to neuroblastoma heterogeneity and complexity.

Main Results:

• Current preclinical models offer valuable insights but do not fully recapitulate human cancer, including rare diseases like neuroblastoma.
• Neuroblastoma presents unique modeling challenges due to disease heterogeneity and limited patient-derived specimens.
• Existing models require further development to enhance their accuracy and clinical applicability.

Conclusions:

• Novel, advanced preclinical models are urgently needed to improve the understanding of cancer development and progression.
• Enhanced models are crucial for accurate evaluation of therapeutic strategies, particularly for rare and heterogeneous cancers like neuroblastoma.
• The development of clinically relevant preclinical systems is vital for informing patient treatment decisions.